Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NewLink Genetics Corp (NASDAQ:NLNK)

10.08
Delayed Data
As of Oct 20
 -0.21 / -2.04%
Today’s Change
5.90
Today|||52-Week Range
25.17
-1.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues15.3M12.7M2.8M10.4M
 
 
 
 
 
Depreciation And Amortization332.0K548.0K360.0K347.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses31.9M26.1M23.6M26.8M
 
 
 
 
 
Research And Development24.5M19.5M15.7M18.2M
 
 
 
 
 
Total Operating Expenses32.2M26.7M24.0M27.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.9M-14.0M-21.2M-16.7M
 
 
 
 
 
Interest Expense On Debt5.0K4.0K106.0K7.0K
 
 
 
 
 
Other Expenses-44.0K75.0K-4.0K-109.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.8M-13.8M-21.2M-16.7M
 
 
 
 
 
Income Taxes-1.3M-336.0K-310.0K0.00
 
 
 
 
Net Income-15.5M-13.5M-20.9M-16.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS29.0M29.1M29.2M29.2M
 
 
 
 
 
Shares To Calculate EPS Diluted29.0M29.1M29.2M29.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.54-$0.46-$0.72-$0.57
 
 
 
 
 
EPS Diluted-$0.54-$0.46-$0.72-$0.57